IL15 and neoplasm: proposed TIGIT expression as a predictive rather than prognostic biomarker for reactive tumor-infiltrating immune cells in soft sarcoma tissue in an elegant investigation on IL-15 and TIGIT blockade therapy to reactive tumor-infiltrating immune cells (164).